Ultralife
ULBI
Ultralife (ULBI) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.15
- EPS estimate
- $0.19
- EPS surprise
- −21.05%
- Revenue surprise
- −12.83%
- Revenue
- $47.9M
- Revenue estimate
- $55.0M
- Reported
- Aug 7, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | $0.19 | $0.15 | −21.05% | $47.9M | SEC |
| Q1 2026 | May 8, 2026 | $0.15 | −$0.03 | −120.00% | $47.4M | SEC |
| Q4 2025 | Mar 10, 2026 | $0.24 | −$0.45 | −287.50% | $48.5M | SEC |
| Q3 2025 | Nov 17, 2025 | $0.21 | −$0.07 | −133.33% | $43.4M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.13 | $0.05 | −61.54% | $48.6M | SEC |
| Q1 2025 | May 9, 2025 | $0.14 | $0.11 | −21.43% | $50.7M | SEC |
| Q4 2024 | Apr 1, 2025 | $0.13 | $0.01 | −92.31% | $43.9M | SEC |
| Q3 2024 | Nov 8, 2024 | $0.18 | $0.02 | −88.89% | $35.7M | SEC |
| Q2 2024 | Jul 25, 2024 | $0.12 | $0.18 | +50.00% | $43.0M | SEC |
| Q1 2024 | Apr 25, 2024 | $0.09 | $0.18 | +100.00% | $41.9M | SEC |
| Q4 2023 | Feb 15, 2024 | $0.07 | $0.17 | +142.86% | $44.5M | SEC |
| Q3 2023 | Oct 26, 2023 | $0.08 | $0.08 | +0.00% | $39.5M | SEC |
| Q2 2023 | Jul 27, 2023 | $0.02 | $0.21 | +950.00% | $42.7M | SEC |
| Q1 2023 | Apr 27, 2023 | −$0.10 | −$0.02 | +80.00% | $31.9M | SEC |
| Q4 2022 | Mar 2, 2023 | $0.09 | −$0.01 | −111.11% | $36.1M | SEC |
| Q3 2022 | Oct 27, 2022 | $0.04 | −$0.01 | −125.00% | $33.2M | — |
| Q2 2022 | Jul 28, 2022 | $0.01 | $0.03 | +200.00% | $32.1M | — |
| Q1 2022 | Apr 28, 2022 | −$0.06 | −$0.01 | +83.33% | $30.4M | — |
| Q4 2021 | Feb 3, 2022 | −$0.04 | −$0.07 | −75.00% | $23.8M | — |
| Q3 2021 | Oct 28, 2021 | $0.08 | −$0.04 | −150.00% | $21.8M | — |
Quarterly revenue
Frequently asked questions
When did Ultralife (ULBI) last report earnings?
Ultralife last reported on Aug 7, 2026, covering fiscal Q2 2026.
Did ULBI beat earnings estimates?
No. Ultralife reported EPS of $0.15 for Q2 2026 against a $0.19 estimate — a 21.05% miss.
How much revenue did ULBI report last quarter?
Ultralife reported $47.9M in revenue for Q2 2026, against a consensus estimate of $55.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.